Arsenic Thiolation and the role of sulfate-reducing bacteria from the human intestinal tract

Environmental Health Perspectives

Volumn 122, Issue 8, 2014, Pages 817-822

  Dc Rubin, Sergio S C ^a,b   Alava, Pradeep ^c   Zekker, Ivar ^d   Du Laing, Gijs ^a   Van de Wiele, Tom ^a  

^a GHENT UNIVERSITY   (Belgium)

^b Centro Nacional de Investigaciones Biotecnologicas CNIB   (Bolivia)

^c U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^d UNIVERSITY OF TARTU   (Estonia)

Author keywords

[No Author keywords available]

Indexed keywords

METHANEARSONIC ACID; MOLYBDATE SODIUM; ARSENIC; HYDROGEN SULFIDE; ORGANOARSENIC DERIVATIVE;

ARSENIC POISONING; ARTICLE; COLON FLORA; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; DESULFOVIBRIO DESULFURICANS; DNA EXTRACTION; ELECTROSPRAY; FECES MICROFLORA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; MICROBIAL COMMUNITY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SULFATE REDUCING BACTERIUM; TOXICOKINETICS; BACTERIA; COLON; FECES; GASTROINTESTINAL TRACT; METABOLISM; MICROBIOLOGY;

ARSENIC; ARSENICALS; BACTERIA; COLON; FECES; GASTROINTESTINAL TRACT; HUMANS; HYDROGEN SULFIDE;

EID: 84905234456     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1307759     Document Type: Article

References (39)

1. Alava P, Tack F, Laing GD, Van de Wiele T. 2012. HPLC-ICP-MS method development to monitor arsenic speciation changes by human gut microbiota. Biomed Chromatogr 26(4):524-533.
2. Alava P, Tack F, Laing GD, Van de Wiele T. 2013. Arsenic undergoes significant speciation changes upon incubation of contaminated rice with human colon micro biota. J Hazard Mater 262:1237-1244.
3. Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, et al. 2011. Enterotypes of the human gut microbiome. Nature 473(7346):174-180.
4. Boever PD, Deplancke B, Verstraete W. 2000. Fermentation by gut microbiota cultured in a simulator of the human intestinal microbial ecosystem Is improved by supplementing a soygerm powder. J Nutr 130(10):2599-2606.
5. Cantor KP, Lubin JH. 2007. Arsenic, internal cancers, and issues in inference from studies of low-level exposures in human populations. Toxicol Appl Pharm 222(3):252-257.
6. Castro HF, Williams NH, Ogram A. 2000. Phylogeny of sulfate-reducing bacteria. FEMS Microbiol Ecol 31(1):1-9.
7. Conklin SD, Ackerman AH, Fricke MW, Creed PA, Creed JT, Kohan MC, et al. 2006. In vitro biotransformation of an arsenosugar by mouse anaerobic cecal microflora and cecal tissue as examined using IC-ICP-MS and LC-ESI-MS/MS. Analyst 131(5):648-655.
8. De Weirdt R, Possemiers S, Vermeulen G, Moerdijk-Poortvliet TC, Boschker HT, Verstraete W, et al. 2010. Human faecal microbiota display variable patterns of glycerol metabolism. FEMS Microbiol Ecol 74(3):601-611.
9. Diaz-Bone RA, Hollmann M, Wuerfel O, Pieper D. 2009. Analysis of volatile arsenic compounds formed by intestinal microorganisms: rapid identification of new metabolic products by use of simultaneous EI-MS and ICP-MS detection after gas chromatographic separation. J Anal Atom Spectrom 24(6):808-814.
10. Dopp E, von Recklinghausen U, Diaz-Bone R, Hirner AV, Rettenmeier AW. 2010. Cellular uptake, subcellular distribution and toxicity of arsenic compounds in methylating and non-methylating cells. Environ Res 110(5):435-442.
11. Fisher JC, Wallschlager D, Planer-Friedrich B, Hollibaugh JT. 2007. A new role for sulfur in arsenic cycling. Environ Sci Technol 42(1):81-85.
12. Francesconi KA. 2010. Arsenic species in seafood: origin and human health implications. Pure Appl Chem 82(2):373-381.
13. Gilmour CC, Elias DA, Kucken AM, Brown SD, Palumbo AV, Schadt CW, et al. 2011. Sulfate-reducing bacterium Desulfovibrio desulfuricans ND132 as a model for understanding bacterial mercury methylation. Appl Environ Microbiol 77(12):3938-3951.
14. Grossman JP, Postgate JR. 1953. Cultivation of sulphate-reducing bacteria. Nature 171(4353):600-602.
15. Hansen HR, Raab A, Jaspars M, Milne BF, Feldmann J. 2004. Sulfur-containing arsenical mistaken for dimethylarsinous acid [DMA(III)] and identified as a natural metabolite in urine: major implications for studies on arsenic metabolism and toxicity. Chem Res Toxicol 17(8):1086-1091.
16. Heitland P, Koster HD. 2008. Fast determination of arsenic species and total arsenic in urine by HPLC-ICP-MS: concentration ranges for unexposed German inhabitants and clinical case studies. J Anal Toxicol 32(4):308-314.
17. Hernandez A, Marcos R. 2008. Genetic variations associated with interindividual sensitivity in the response to arsenic exposure. Pharmacogenomics 9(8):1113-1132.
18. Kubachka KM, Kohan MC, Conklin SD, Herbin-Davis K, Creed JT, Thomas DJ. 2009a. In vitro biotransformation of dimethylarsinic acid and trimethylarsine oxide by anaerobic microflora of mouse cecum analyzed by HPLC-ICP-MS and HPLC-ESI-MS. J Anal Atom Spectrom 24(8):1062-1068.
19. Kubachka KM, Kohan MC, Herbin-Davis K, Creed JT, Thomas DJ. 2009b. Exploring the in vitro formation of trimethylarsine sulfide from dimethylthioarsinic acid in anaerobic microflora of mouse cecum using HPLC-ICP-MS and HPLC-ESI-MS. Toxicol Appl Pharmacol 239(2):137-143.
20. Ley RE, Peterson DA, Gordon JI. 2006. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124(4):837-848.
21. Mandal BK, Suzuki KT. 2002. Arsenic round the world: a review. Talanta 58(1):201-235.
22. Marchesi JR. 2011. Human distal gut microbiome. Environ Microbiol 13(12):3088-3102.
23. Molly K, Vandewoestyne M, Desmet I, Verstraete W. 1994. Validation of the Simulator of the Human Intestinal Microbial Ecosystem (SHIME) reactor using microorganism-associated activities. Microb Ecol Health D 7(4):191-200.
24. Muyzer G, de Waal EC, Uitterlinden AG. 1993. Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA. Appl Environ Microbiol 59(3):695-700.
25. Muyzer G, Stams AJ. 2008. The ecology and biotechnology of sulphate-reducing bacteria. Nat Rev Microbiol 6(6):441-454.
26. Naranmandura H, Carew MW, Xu S, Lee J, Leslie EM, Weinfeld M, et al. 2011. Comparative toxicity of arsenic metabolites in human bladder cancer EJ-1 cells. Chem Res Toxicol 24(9):1586-1596.
27. Nava GM, Carbonero F, Croix JA, Greenberg E, Gaskins HR. 2012. Abundance and diversity of mucosa-associated hydrogenotrophic microbes in the healthy human colon. ISME J 6(1):57-70.
28. Pinyayev TS, Kohan MJ, Herbin-Davis K, Creed JT, Thomas DJ. 2011. Preabsorptive metabolism of sodium arsenate by anaerobic microbiota of mouse cecum forms a variety of methylated and thiolated arsenicals. Chem Res Toxicol 24(4):475-477.
29. Possemiers S, Bolca S, Grootaert C, Heyerick A, Decroos K, Dhooge W, et al. 2006. The prenylflavonoid Isoxanthohumol from hops (Humulus lupulus L.) is activated into the potent phytoestrogen 8-prenylnaringenin in vitro and in the human intestine. J Nutr 136(7):1862-1867.
30. Raml R, Rumpler A, Goessler W, Vahter M, Li L, Ochi T, et al. 2007. Thio-dimethylarsinate is a common metabolite in urine samples from arsenic-exposed women in Bangladesh. Toxicol Appl Pharm 222(3):374-380.
31. Rowland IR, Davies MJ. 1981. In vitro metabolism of inorganic arsenic by the gastro-intestinal microflora of the rat. J Appl Toxicol 1(5):278-283.
32. Spence C, Whitehead TR, Cotta MA. 2008. Development and comparison of SYBR Green quantitative real-time PCR assays for detection and enumeration of sulfate-reducing bacteria in stored swine manure. J Appl Microbiol 105(6):2143-2152.
33. Sun GX, Van de Wiele T, Alava P, Tack F, Du Laing G. 2012. Arsenic in cooked rice: effect of chemical, enzymatic and microbial processes on bioaccessibility and speciation in the human gastrointestinal tract. Environ Pollut 162:241-246.
34. Van de Wiele T, Gallawa CM, Kubachka KM, Creed JT, Basta N, Dayton EA, et al. 2010. Arsenic metabolism by human gut microbiota upon in vitro digestion of contaminated soils. Environ Health Perspect 118:1004-1009; doi:10.1289/ehp.0901794.
35. Vermeiren J. 2011. Intestinal Microbial Metabolic Processes in Inflammatory Bowel Diseases [PhD Dissertation]. Ghent, Belgium:Ghent University.
36. Watanabe T, Hirano S. 2012. Metabolism of arsenic and its toxicological relevance. Arch Toxicol 87(6):969-979.
37. Yathavakilla SKV, Fricke M, Creed PA, Heitkemper DT, Shockey NV, Schwegel C, et al. 2008. Arsenic speciation and identification of monomethylarsonous acid and monomethylthioarsonic acid in a complex matrix. Anal Chem 80(3):775-782.
38. Yoshida K, Kuroda K, Inoue Y, Chen H, Date Y, Wanibuchi H, et al. 2001. Metabolism of dimethylarsinic acid in rats: production of unidentified metabolites in vivo. Appl Organomet Chem 15(6):539-547.
39. Yoshinaga M, Cai Y, Rosen BP. 2011. Demethylation of methylarsonic acid by a microbial community. Environ Microbiol 13(5):1205-1215.